-
-
-
-
-
-
-
CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
-
-
-
-
-
-
-
CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) PT Lowered to $3.25 at Piper Sandler
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) PT Raised to $3.59 at BMO Capital
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) Tops Q3 EPS by 23c
-
-
-
-
-
-
-
CytomX Therapeutics to Report First Quarter 2023 Financial Results on May 9, 2023
-
-
-
-
-
-
-
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
-
1,217,589 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

